Q1 2026: Strong Revenue Growth and Therapeutics Pipeline Advancement

Go back to Q1 2026: Strong Revenue Growth and Therapeutics Pipeline Advancement
TRANS-LUX CORPORATION (NASDAQ: TLX) Delayed: 11.94 +0.20 (1.70%)
Previous Close $11.74    52 Week High $2.18 
Open $11.84    52 Week Low $0.30 
Day High $11.95    P/E N/A 
Day Low $11.84    EPS $-3.32 
Volume 140,977       

TRANS-LUX CORPORATION (NASDAQ: TLX) Delayed: 11.94 +0.20 (1.70%)
Previous Close $11.74    52 Week High $2.18 
Open $11.84    52 Week Low $0.30 
Day High $11.95    P/E N/A 
Day Low $11.84    EPS $-3.32 
Volume 140,977